This year, the European Commission will announce its proposal for the revision of European pharmaceutical legislation. As a leader in innovation, Finland must ensure that the Commission’s revisions will continue to ensure Europe’s competitiveness in the future.
First there was e-health, then came mobile health and now comes Smart Health
It is difficult to define in simple words what the transition of healthcare means. Digitalisation and data are essential drivers of the change but how to best put into words what is currently happening? One of the excellent attempts is the new concept “Smart Health”.
The paediatric population is primarily healthy, rendering paediatric drug development research challenging due to the limited number of children typically impacted by a medical condition.